Business

Sleeping Aids Market in Europe – Industry Insights, Share, Key Players and Forecast by 2024

Sleep Aids Market in Europe
Press Release

The Europe sleeping aids market was valued at $14.8 billion in 2015 and is forecasted to grow at a CAGR of 6.2% during forecast period. Various sleep disorders are hampering the lives of people in the region, due to increasing tobacco and alcohol consumption, rising aging population, growing population base working in night shifts and changing lifestyle habits of the Europeans. Sleep disorders such as insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking and others greatly affect the population base in the European region.

Sleeping aids namely mattress & pillow, sleep laboratories, medication, sleep apnea devices and others are largely used for the above-mentioned sleeping disorders. Mattress & pillows held the largest share in the European sleeping aids market and contributed 43% in 2015. Amongst all the sleep related problems people are being majorly affected by insomnia and sleep apnea in the Europe.

Download sample copy of this report at: https://www.psmarketresearch.com/market-analysis/europe-sleeping-aids-market/report-sample

There are various technological advancements related to sleeping aids products that are under development in the region. For instance, an application known as Snoozeal has been developed in the U.S. for treating problems related to sleep which is now under trial in the Europe. It is a smartphone controlled anti-snoring/sleep apnea medical device, that has received U.S. Food and Drug Association (USFDA) approval in December 2016. The device addresses the root cause of excessive relaxation and loss of tongue muscle tone during sleep.

The device uses a wireless technology to exercise the tongue to treat the physiological cause of snoring and sleep apnea and the smart phone app monitors the user and controls the progress of the treatment. Also, the latest DOMINO version 2.8.0 by Somnomedics Gmbh provides high quality and user-friendly collection and analysis of both the ambulatory (Polysomnography) PSG and the stationary PSG recordings with the SOMNOscreen, SOMNOscreen plus and the new device SOMNO HD and this software was developed in August 2016.

Europe Sleeping Aids Industry Key Players:

1- Sanofi S.A.

2- Koninklijke Philips N.V.

3- GlaxoSmithKline PLC

4- Merck & Co. Inc.

5- Pfizer Inc.

6- Roche Holding AG

7- AstraZeneca plc

8- Drive Medical Ltd.

9- Somnomedics Gmbh

10- Cardinal Health.

This post was originally published on Raleigh Recorder

RSS news